The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Global Effects of Smoking, of Quitting, and of Taxing Tobacco
Open accessAbstract
O n the basis of current smoking patterns, with a global ave rage of about 50% of young men and 10% of young women becoming smokers and relatively few stopping, annual tobacco-attributable deaths will rise from about 5 million in 2010 to more than 10 million a few decades hence, 1-3 as the young smokers of today reach middle and old age.This increase is due partly to population growth and partly to the fact that, in some large populations, generations in which few people smoked substantial numbers of cigarettes throughout adult life are being succeeded by generations in which many people did so.There were about 100 million deaths from tobacco in the 20th century, most in developed countries.2,3 If current smoking patterns persist, tobacco will kill about 1 billion people this century, mostly in low-and middle-income countries.About half of these deaths will occur before 70 years of age.[1][2][3][4] The 2013 World Health Assembly called on governments to reduce the prevalence of smoking by about a third by 2025, 5 which would avoid more than 200 million deaths from tobacco during the remainder of the century.2,3 Price is the key determinant of smoking uptake and cessation.[6][7][8][9] Worldwide, a reduction of about a third could be achieved by doubling the inflation-adjusted price of cigarettes, which in many low-and middle-income countries could be achieved by tripling the specific excise tax on tobacco.Other interventions recommended by the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) and the WHO six-point MPOWER initiative 4 could also help reduce consumption 7,8 and could help make substantial increases in specific excise taxes on tobacco politically acceptable.Without large price increases, a reduction in smoking by a third would be difficult to achieve.The WHO has also called for countries to achieve a 25% reduction between 2008 and 2025 in the probability of dying from noncommunicable disease between 30 and 70 years of age. 10 Widespread cessation of smoking is the most important way to help achieve this goal, because smoking throughout adulthood substantially increases mortality from several major noncommunicable diseases (and from tuberculosis).[1][2][3][11][12][13][14][15][16][17][18][19] To help achieve a large reduction in smoking in the 2010s or 2020s, governments, health professionals, journalists, and other opinion leaders should appreciate the full eventual hazards of smoking cigarettes from early adulthood, the substantial benefits of stopping at various ages, the eventual magnitude of the epidemic of tobacco-attributable deaths if current smoking patterns persist, and the effectiveness of tax increases and other interventions to reduce cigarette consumption. Thr ee K ey Messages for Smok er s in the 21s t Cent ur yFirst, the risk is big.Large studies in the United Kingdom, the United States, Japan, and India have examined the eventual effects on mortality in populations of menThe New England Journal of Medicine Downloaded from nejm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the recent decline in tobacco smoking in the developed countries [2] has had more to do with policies justified by scientific evidence (e.g.taxes and availability restrictions) than to clinical interventions derived from research (e.g.nicotine replacement therapy).”
From Screening, Brief Intervention and Referral to Treatment: implications of SAMHSA's SBIRT initiative for substance abuse policy and practice (2017) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“raising taxes on tobacco is the least often implemented measure of those established by the FCTC”
From The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study. (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“an increase in the inflation-adjusted price of tobacco is a realistic and effective strategy to reduce smoking”
The cited source says what the claim attributes to it.
In the citing paper
“only a few countries have substantially increased specific excise taxes on tobacco in an attempt to reduce smoking”
The cited source says what the claim attributes to it.
In the citing paper
“despite the highly addictive nature of cigarettes, the demand for tobacco is strongly influenced by its price”
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Self-citationFinucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Self-citationSmoking and Carcinoma of the Lung
Doll, R., & Hill, A. B. (1950) · BMJ · doi:10.1136/bmj.2.4682.739 · Cited by 1,999
21st-Century Hazards of Smoking and Benefits of Cessation in the United States
Jha, P., Ramasundarahettige, C., Landsman, V., Rostron, B., Thun, M., Anderson, R. N., McAfee, T., & Peto, R. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1211128 · Cited by 1,767
Self-citationDisease Control Priorities in Developing Countries
Mosley, W. H. (1993) · World Bank, Washington, DC eBooks · doi:10.1596/0-1952-0990-7 · Cited by 1,400
Mackay, J. M., & Eriksen, M. P. (2002) · Medical Entomology and Zoology · Cited by 1,322
50-Year Trends in Smoking-Related Mortality in the United States
Thun, M. J., Carter, B. D., Feskanich, D., Freedman, N. D., Prentice, R., Lopez, A. D., Hartge, P., & Gapstur, S. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1211127 · Cited by 1,177
Electronic cigarettes for smoking cessation: a randomised controlled trial.
Bullen, C., Howe, C., Laugesen, M., McRobbie, H., Parag, V., Williman, J., & Walker, N. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61842-5 · Cited by 1,094
Effect of smoke-free workplaces on smoking behaviour: systematic review
Fichtenberg, C. M., & Glantz, S. A. (2002) · BMJ · doi:10.1136/bmj.325.7357.188 · Cited by 1,072
Research works printed but not linked: 4
- Jha P, 2011, Econ Polit Wkly, 42, 44
- 1999, MMWR Morb Mortal Wkly Rep, 48, 140
- Callinan JE, 2010, Cochrane Database Syst Rev, 4, CD005992
- Bala MM, 2013, Cochrane Database Syst Rev, 6, CD004704
Cited by
Reitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30819-x · Cited by 2,028
Reitsma, M. B., Kendrick, P. J., Ababneh, E., Abbafati, C., Abbasi-Kangevari, M., Abdoli, A., Abedi, A., Abhilash, E. S., Abila, D. B., Aboyans, V., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01169-7 · Cited by 1,759
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Akinyemiju, T. F., Al Lami, F. H., Alam, T., Alizadeh-Navaei, R., Allen, C., Alsharif, U., Alvis-Guzman, N., Amini, E., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2706 · Cited by 1,518
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198
Mobile phone-based interventions for smoking cessation
Whittaker, R., McRobbie, H., Bullen, C., Rodgers, A., & Gu, Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006611.pub4 · Cited by 1,079
Metadata
- Authors
- Jha, P., & Peto, R.
- Affiliations
- St. Michael's Hospital (CA)
- University of Oxford (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-01-02
- Volume
- 370
- Issue
- 1
- Pages
- 60-68
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1986333129
- Cited by
- 843
- References
- 52
- Citations by year
- 2026: 45 · 2025: 56 · 2024: 63 · 2023: 46 · 2022: 69 · 2021: 61 · 2020: 80 · 2019: 64 · 2018: 79 · 2017: 89 · 2016: 63 · 2015: 94 · 2014: 32
- FWCI
- 61.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK (16896)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Fiscal Studies
- Keywords
- smoking, smoking cessation, tobacco excise tax, tobacco pricing, non-communicable diseases, tobacco control, Framework Convention on Tobacco Control, smoking prevalence
- MeSH terms
- Smoking Prevention, Female, Humans, Life Expectancy, Male, Smoking, Taxes, Smoking Cessation, Tobacco Products
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global Effects of Smoking, of Quitting, and of Taxing Tobacco. https://app.cochat.ai/papers/10.1056/nejmra1308383
- The paper
- Jha, P., & Peto, R. (2014). Global Effects of Smoking, of Quitting, and of Taxing Tobacco. New England Journal of Medicine. https://doi.org/10.1056/nejmra1308383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.